Provider perspectives on beta-lactam therapeutic drug monitoring programs in the critically ill: a protocol for a multicenter mixed-methods study

BACKGROUND: Beta-lactams (i.e., penicillins, cephalosporins, carbapenems, monobactams) are the most widely used class of antibiotics in critically ill patients. There is substantial interpatient variability in beta-lactam pharmacokinetics which renders their effectiveness and safety largely unpredic...

Descripción completa

Detalles Bibliográficos
Autores principales: Barreto, Erin F., Rule, Andrew D., Alshaer, Mohammad H., Roberts, Jason A., Abdul Aziz, Mohd Hafiz, Scheetz, Marc H., Mara, Kristin C., Jannetto, Paul J., Gajic, Ognjen, O’Horo, John C., Boehmer, Kasey R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7992791/
https://www.ncbi.nlm.nih.gov/pubmed/33762025
http://dx.doi.org/10.1186/s43058-021-00134-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7992791/
https://www.ncbi.nlm.nih.gov/pubmed/33762025
http://dx.doi.org/10.1186/s43058-021-00134-9

Ejemplares similares